NgG vaccine（GlaxoSmithKline）

N/A

Report date: 2023/06/28 17:52:38

Base Information

Drug NameNgG vaccine（GlaxoSmithKline）
Drug Alias NameNeisseria gonorrhoeae investigational vaccine（GlaxoSmithKline）
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSexually Transmitted Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPhilippinesSouth Africa +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsSexually Transmitted Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A